We also identified three known poly-glutamine repeat polymorphisms, one in exon 20 of NCOA3.[27], one in exon 15 of NCOR2.[28], and one in exon 4 of SMARCA2[29]; associations with these repeat polymorphisms and breast cancer risk will be examined in future studies. This evidence concerns the gene SMARCA2 and breast carcinoma.